Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Detecting Liver Fibrosis in Patients At-risk

NCT07775638 is registered in ClinicalTrials.gov with Helse Stavanger HF as lead sponsor.

NCT NCT07775638
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07775638 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Detecting Liver Fibrosis in Patients At-risk
Lead sponsor
Helse Stavanger HF
Phase
Observational
Overall status
Not yet recruiting
Start date
August 31, 2026
Completion date
December 31, 2070
Enrollment
1,200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

biomarker in early diagnosis, cirrhoses, liver, fatty liver, liver disease (alcoholic or not), masld (metabolic dysfunction-associated steatotic liver disease), nafld - non-alcoholic fatty liver disease, nash